BackMEDIROM Healthcare Technologies Overview

MEDIROM Healthcare Technologies Receivables

Latest receivables for MRM: $3.5B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$3.53B
↑ 76.26% YoYΔ $1.53B vs prior year quarter

Peer trimmed avg / median

Loading

MEDIROM Healthcare Technologies Receivables History

Loading

MEDIROM Healthcare Technologies vs. peers: Receivables Comparison

Loading

MEDIROM Healthcare Technologies Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MEDIROM Healthcare Technologies (MRM) FAQ

As of the most recent data (December 2025), MRM shows a receivables of $3.5B. That compares with $2B in the prior-year period — up 76.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MRM's receivables is now $3.5B (was $2B) — a 76.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether MEDIROM Healthcare Technologies is outperforming or lagging.

Tracking MRM's receivables over time shows whether MEDIROM Healthcare Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5B That compares with $2B in the prior-year period — up 76.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has MEDIROM Healthcare Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $3.5B) with ownership activity and broader fundamentals.

MEDIROM Healthcare Technologies's receivables is $3.5B; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.